NFKBIA and nasopharyngeal carcinoma: Recently, one study found that multiple loss-of-function mutations were identified in several NF-κB signaling negative regulators tumor necrosis factor a-induced protein 3 (TNFAIP3), NF-κB inhibitor alpha (NFKBIA), and cylindromatosis (CYLD) in NPC.